Speeding the Evaluation of New Drugs and Technologies for the Paediatric Population
Add bookmark
Speeding the Evaluation of New Drugs and Technologies for the Paediatric Population
Add bookmark
Dr. Gonzalo de Miquel, Director, Respiratory Therapy Area at Almirall R&D, speaks to Andrea Charles from Pharma IQ, about the enigma of paediatric research. In this podcast de Miquel discusses the key components of a good paediatric study design, challenges of handling studies for inhalation devices in the paediatric population and what new steps have been taken to speed evaluation of new drugs and technologies for the paediatric population.
[inlinead]
Tags:
Gonzalo de Miquel
Almirall R&D
respiratory therapy
integrated paediatric drug development
paediatric drug development
paediatric study design
inhalation devices
paediatric population
